Results 111 to 120 of about 889,631 (198)

Prognostic factors in surgical treatment of patients with carcinoma of esophagogastric junction

, 2009
Резюме. Протягом останніх років у Європі та США зафіксовано впевнене зростання захворюваності на рак стравохідно-шлункового сполучення (кардії) на фоні зниження частоти раку дистальних відділів шлунка.
Лукавецький, Н.О., Білинський, Б.Т.   +1 more
core   +2 more sources

Signet ring carcinoma of the esophagogastric junction in a Nigerian man

International Journal of Medicine and Medical Sciences, 2012
Globally, the majority of cancers of the esophagogastric junction are adenocarcinomas. Of the four histological subtypes, the signet ring carcinomas are rare. There is a dearth of reports of this relatively rare histological finding from patients in sub-Saharan Africa. We present such a case in 69 year old Nigerian with advanced malignant disease.  
openaire   +1 more source

Manometric Parameters of Esophagogastric Junction Competence: a Systematic Literature Review

The current gold standard for diagnosing gastroesophageal reflux disease (GERD) are pH-monitoring and endoscopy. However, in recent years, HRM has been investigated as a potential diagnostic tool for GERD, given its ability to provide detailed esophageal
Arianna Vittori, Francesca Senzani, Stefano Siboni, Andres R. Latorre-Rodriguez, Marco Sozzi, Sumeet K. Mittal, Emanuele Asti   +6 more
core   +1 more source

Cancer of the Esophagus and Esophagogastric Junction: An Eighth Edition Staging Primer

, 2017
This primer for eighth edition staging of esophageal and esophagogastric epithelial cancers presents separate classifications for the clinical (cTNM), pathologic (pTNM), and postneoadjuvant pathologic (ypTNM) stage groups, which are no longer shared. For
Rice, Thomas W, Goldstraw, Peter, Ishwaran, Hemant, Ferguson, Mark K, Blackstone, Eugene H   +4 more
core   +1 more source

Deciphering the tumor ecosystem dynamics undergoing immunochemotherapy therapy across multiple cancer types unveils the immunosuppressive role of S100A4 in fibroblasts by promoting PD-L1 expression in tumor cells

Frontiers in Cell and Developmental Biology
BackgroundNeoadjuvant therapy (NAT) has transformed cancer treatment by improving surgical outcomes and survival rates, yet resistance mechanisms across multiple cancer types remain unclear.
Bo Yang, Bo Yang, Ruiji Chen, Ruiji Chen, Mali Zu, Jie Yao, Hong Ren, Hong Ren, Yingxue Lin, Yingxue Lin, Bo Zhang, Tianjiao Ji, Yang Liu   +12 more
doaj   +1 more source

Establishment of a Chinese library of patient-derived xenografts from gastrointestinal cancers

BMC Cancer
Background Patient-derived xenografts (PDX) models have been regarded as an important tool for preclinical research. The aim of this study was to establish a Chinese PDX library from gastrointestinal cancers, especially esophageal squamous cell carcinoma
Ying Liu, Wei He, Qi Wu, Jia-Fu Ji, Lin Shen, Chun-Yi Hao, Rui-Ping Xu, Ke-Neng Chen, Nan Wu, Chang-Qi Cao, Ying Hu, Li-Xin Zhang, Huan-Yu Chen, Zhe Hu, Ya-Qi Pan, Wen-Qing Yuan, Jing-Jing Li, Bin Dong, Meng-Fei Liu, Zhen Liu, Fang-Fang Liu, Hong Cai, Zhong-Hu He, Yang Ke   +23 more
doaj   +1 more source

Palliative esophagogastrostomy for inoperable carcinoma of the esophagogastric junction

The Journal of Thoracic and Cardiovascular Surgery, 1970
C L, Johnson, O T, Clagett
openaire   +2 more sources

Management of metastatic esophagogastric junction adenocarcinoma

, 2018
The prognosis of metastatic disease of esophagogastric junction adenocarcinoma remains poor, despite using a variety of regimens using cytotoxic agents.
Imamura, Yu, Watanabe, Masayuki, Baba, Hideo, Toihata, Tasuku   +3 more
core  

High-risk group of upper and middle mediastinal lymph node metastasis in patients with esophagogastric junction carcinoma. [PDF]

Ann Gastroenterol Surg, 2018
Yura M, Takeuchi H, Fukuda K, Nakamura R, Suda K, Wada N, Kawakubo H, Kitagawa Y.   +7 more
europepmc   +1 more source

Risk factors and prognostic implications of upper or middle mediastinal lymph nodes metastasis and recurrence in esophagogastric junction carcinoma. [PDF]

J Gastrointest Oncol
Nozu S, Fukuda T, Shiomi S, Oka D.
europepmc   +1 more source